CMEO Webcast
Premiere Date: Tuesday, September 28, 2010This activity offers CE credit for:
- Physicians (CME)
- Nurses (CNE)
- Pharmacists (ACPE)
All other clinicians will either receive a CME Attendance Certificate or may choose any of the types of CE credit being offered.
Credit Expiration Date: Wednesday, September 28, 2011
Faculty
 |
Keith P. Klugman, MD, PhD William H. Foege Professor of Global Health Rollins School of Public Health Professor of Medicine, Division of Infectious Diseases Emory University School of Medicine Atlanta, GA |
 |
Michael S. Niederman, MD, FACP, FCCP, FCCM (Moderator) Chairman, Department of Medicine Winthrop-University Hospital Professor of Medicine Vice-Chairman, Department of Medicine SUNY at Stony Brook Mineola, NY |
Co-sponsored by
Statement of Need
Pneumococcal disease, which includes pneumococcal pneumonia,
meningitis, and bacteremia, is associated with substantial morbidity and mortality, and is considered the top killer among vaccine-preventable diseases. Yet, vaccination rates among adults remain suboptimal. The Centers for Disease Control and Prevention has called for increased efforts to vaccinate at-risk populations against pneumococcal disease. Adherence to accepted treatment guidelines and recommendations can
provide a framework for improving early recognition, choosing appropriate antibiotic therapy, and implementing vaccination in high-risk populations. In this interactive webcast, expert faculty will outline strategies for early identification of patients at high risk for infection, emphasizing the importance of timely vaccination, and discuss strategies for prevention and treatment of pneumococcal disease supported by current guidelines.
- Rehm SJ, Farley MM, File TM Jr, et al. Higher pneumococcal disease vaccination rates needed to protect more at-risk US adults. Postgrad Med 2009;121:101-105.
Activity Goal
To develop guideline-based and evidence-based strategies for appropriate selection of patients for vaccination against pneumococcal disease.
Learning Objectives
At the end of this CE activity, participants should be able to:
- Recognize the role of vaccination of high-risk population in the prevention of pneumococcal disease.
- Integrate established treatment guidelines into clinical practice to improve prevention and treatment of pneumococcal disease in high-risk patients.
- Develop strategies to improve early recognition and diagnosis of pneumococcal disease.
The following learning objectives pertain only to those requesting CNE credit:
- Recognize the role of vaccination of high-risk population in the prevention of pneumococcal disease.
- Identify established treatment guidelines to improve prevention and treatment of pneumococcal disease in high-risk patients.
- Describe strategies to improve early recognition and diagnosis of pneumococcal disease.
Target Audience
Physicians, physician assistants, nurses, nurse practitioners, and pharmacists with an interest in pneumococcal disease prevention.
Financial Support
USF Health and CME Outfitters, LLC, gratefully acknowledge an educational grant from Pfizer Inc. in support of this CE activity.
Credit Information
CME Credit (Physicians):
USF Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
USF Health designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Creditâ„¢. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Note to Physician Assistants: AAPA accepts Category I credit from AOACCME, Prescribed credit from AAFP, and AMA Category I CME credit for the PRA from organizations accredited by ACCME.
CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1.0 contact hours.
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited
by the Accreditation Council for Pharmacy Education
as a provider of continuing pharmacy education.
1.0 contact hours (0.1 CEUs)
Universal Program Number:
376-999-10-020-L01-P (live presentation)
376-999-10-020-H01-P (recorded programs)
Activity Type: knowledge-based
Post-tests, credit request forms, and activity evaluations can be completed online at www.cmeoutfitters.com/test, and participants can print their certificate or statement of credit immediately (70% pass rate required). This website supports all browsers except Internet Explorer for Mac.
Disclosure of Relevant Financial Relationships with Commercial Interests
USF Health and CME Outfitters, LLC, adhere to the ACCME Standards, as well as those of the ACPE, APA, and ANCC, regarding commercial support of continuing medical education. It is the policy of USF Health and CME Outfitters, LLC, that the faculty and planning committee disclose real or apparent conflicts of interest relating to the topics of this educational activity, that relevant conflict(s) of interest are resolved, and also that speakers will disclose any unlabeled/unapproved use of drug(s) or device(s) during their presentation.
A conflict of interest is created when individuals in a position to control the content of CME have a relevant financial relationship with a commercial interest which therefore may bias his/her opinion and teaching. This may include receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, stocks or other financial benefits.
USF Health will identify, review and resolve all conflicts of interest that speakers, authors or planners disclose prior to an educational activity being delivered to learners. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.
Relevant financial relationships exist between the following individuals and commercial interests:
Professor Klugman has disclosed that he serves as a consultant to Dow Pharmaceutical Sciences, Inc., Forest Laboratories, GlaxoSmithKline, Merck & Co., Inc., Novartis Pharmaceuticals Corporation, and Pfizer Inc. He receives research/grants from Pfizer Inc.
Dr. Niederman has disclosed that he is on the advisory board or panel of and serves as a consultant to Bayer Corp., Johnson & Johnson Pharmaceutical Research & Development, Merck & Co., Inc., and Pfizer Inc. He receives grants from Bayer Corp. and honoraria from Astellas Pharma Inc., Johnson & Johnson Pharmaceutical Research & Development, Merck & Co., Inc., and Pfizer Inc.
Disclosures were obtained from the planning committee members and are on file in the USF Health, Office of Continuing Professional Development (OCPD) for review. Disclosures were obtained from the USF Health OCPD staff: Nothing to Disclose.
Unlabeled Use Disclosure
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
USF Health, CME Outfitters, LLC, the faculty, and Pfizer Inc. do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
Equal Opportunity Statement:
Events, activities, programs and facilities of the University of South Florida are available to all without regard to race, color, marital status, gender, sexual orientation, religion, national origin, disability, age, Vietnam or disabled veteran status as provided by law and in accordance with the university’s respect for personal dignity.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).
WC-010-092810-02
